Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00WVI
|
||||
Former ID |
DIB015283
|
||||
Drug Name |
AS-1907417
|
||||
Synonyms |
AS-1535907; AS-1669058; AS-179009; AS-1907417; GPR119 agonists (type 2 diabetes); GPR119 agonists (type 2 diabetes), Astellas Pharma
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Non-insulin dependent diabetes [ICD10:E11.9] | Investigative | [541060] | ||
Company |
Astellas Pharma Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H27N3O4S
|
||||
InChI |
InChI=1S/C19H27N3O4S/c23-17(24)6-1-3-13-7-9-22(10-8-13)19-15-11-27(25,26)12-16(15)20-18(21-19)14-4-2-5-14/h13-14H,1-12H2,(H,23,24)
|
||||
InChIKey |
NFFANIJTECFGGM-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Glucose-dependent insulinotropic receptor | Target Info | Agonist | [543393] | |
KEGG Pathway | cAMP signaling pathway | ||||
Insulin secretion | |||||
WikiPathways | Incretin Synthesis, Secretion, and Inactivation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.